S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
How This Trader Banked A 97% Win Rate (Ad)pixel
Game-Changing News For Tesla Investors 
Microsoft Is The New Safe Haven
How This Trader Banked A 97% Win Rate (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
DOW New Hghs Coming Sooner Than Later
The gold catalyst we’ve waited for (Ad)
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Why did Sarepta Therapeutics Stock Plummet?
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
How This Trader Banked A 97% Win Rate (Ad)pixel
Game-Changing News For Tesla Investors 
Microsoft Is The New Safe Haven
How This Trader Banked A 97% Win Rate (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
DOW New Hghs Coming Sooner Than Later
The gold catalyst we’ve waited for (Ad)
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Why did Sarepta Therapeutics Stock Plummet?
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
How This Trader Banked A 97% Win Rate (Ad)pixel
Game-Changing News For Tesla Investors 
Microsoft Is The New Safe Haven
How This Trader Banked A 97% Win Rate (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
DOW New Hghs Coming Sooner Than Later
The gold catalyst we’ve waited for (Ad)
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Why did Sarepta Therapeutics Stock Plummet?
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
How This Trader Banked A 97% Win Rate (Ad)pixel
Game-Changing News For Tesla Investors 
Microsoft Is The New Safe Haven
How This Trader Banked A 97% Win Rate (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
DOW New Hghs Coming Sooner Than Later
The gold catalyst we’ve waited for (Ad)
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Why did Sarepta Therapeutics Stock Plummet?
NASDAQ:ISRG

Intuitive Surgical - ISRG Competitors

$246.68
+6.18 (+2.57%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$242.12
$247.37
50-Day Range
$224.75
$261.73
52-Week Range
$180.07
$308.97
Volume
1.55 million shs
Average Volume
1.71 million shs
Market Capitalization
$86.40 billion
P/E Ratio
67.40
Dividend Yield
N/A
Price Target
$273.83

ISRG vs. EW, ZBH, ALGN, REGN, ZTS, VRTX, BSX, GSK, HCA, and BDX

Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Align Technology (ALGN), Regeneron Pharmaceuticals (REGN), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX), Boston Scientific (BSX), GSK (GSK), HCA Healthcare (HCA), and Becton, Dickinson and (BDX). These companies are all part of the "medical" sector.

Intuitive Surgical vs.

Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking.

In the previous week, Edwards Lifesciences had 1 more articles in the media than Intuitive Surgical. MarketBeat recorded 13 mentions for Edwards Lifesciences and 12 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 0.74 beat Edwards Lifesciences' score of 0.17 indicating that Intuitive Surgical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Intuitive Surgical
6 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Edwards Lifesciences presently has a consensus target price of $88.95, indicating a potential upside of 8.76%. Intuitive Surgical has a consensus target price of $273.83, indicating a potential upside of 10.77%. Given Intuitive Surgical's stronger consensus rating and higher probable upside, analysts plainly believe Intuitive Surgical is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
1 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.39
Intuitive Surgical
0 Sell rating(s)
5 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.71

Edwards Lifesciences received 296 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 72.89% of users gave Edwards Lifesciences an outperform vote while only 70.22% of users gave Intuitive Surgical an outperform vote.

CompanyUnderperformOutperform
Edwards LifesciencesOutperform Votes
1272
72.89%
Underperform Votes
473
27.11%
Intuitive SurgicalOutperform Votes
976
70.22%
Underperform Votes
414
29.78%

Edwards Lifesciences has higher earnings, but lower revenue than Intuitive Surgical. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$5.38 billion9.21$1.52 billion$2.4433.52
Intuitive Surgical$6.22 billion13.92$1.32 billion$3.6667.54

Edwards Lifesciences has a net margin of 28.27% compared to Intuitive Surgical's net margin of 21.25%. Edwards Lifesciences' return on equity of 26.05% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences 28.27% 26.05% 18.36%
Intuitive Surgical 21.25% 11.27% 9.86%

Edwards Lifesciences has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.

80.4% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 82.0% of Intuitive Surgical shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.9% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Intuitive Surgical beats Edwards Lifesciences on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISRG vs. The Competition

MetricIntuitive SurgicalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$86.58B$6.77B$4.29B$5.86B
Dividend YieldN/A1.31%5.99%4.46%
P/E Ratio67.5424.8999.6812.08
Price / Sales13.9233.283,489.0257.96
Price / Cash49.0118.3619.8157.15
Price / Book7.863.124.535.07
Net Income$1.32B$118.97M$114.48M$190.42M
7 Day Performance5.07%-1.73%-1.72%-0.94%
1 Month Performance5.83%-9.43%-5.81%-5.87%
1 Year Performance-12.74%0.02%-14.36%-16.98%

Intuitive Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
2.4967 of 5 stars
$79.48
+1.6%
$88.95
+11.9%
-26.7%$48.35B$5.38B32.5717,300
ZBH
Zimmer Biomet
2.32 of 5 stars
$125.26
-1.1%
$133.56
+6.6%
+5.6%$26.31B$6.94B113.8718,000Insider Selling
ALGN
Align Technology
3.1604 of 5 stars
$318.17
-0.8%
$358.78
+12.8%
-24.2%$24.38B$3.73B69.0223,165
REGN
Regeneron Pharmaceuticals
2.4636 of 5 stars
$760.30
-0.8%
$815.38
+7.2%
+9.6%$83.12B$12.17B19.8811,851Analyst Report
ZTS
Zoetis
2.561 of 5 stars
$163.57
-0.6%
$223.83
+36.8%
-14.6%$75.80B$8.08B36.3513,800
VRTX
Vertex Pharmaceuticals
2.7382 of 5 stars
$294.27
-0.3%
$327.10
+11.2%
+20.9%$75.65B$8.93B22.944,800Analyst Report
Insider Selling
BSX
Boston Scientific
2.5741 of 5 stars
$47.97
-0.7%
$51.50
+7.4%
+10.2%$68.83B$12.68B106.6045,000
GSK
GSK
2.3144 of 5 stars
$33.58
-0.4%
N/A-18.2%$68.74B$36.28B3.9190,096
HCA
HCA Healthcare
2.6485 of 5 stars
$247.47
-1.3%
$269.41
+8.9%
-1.1%$68.54B$60.23B12.87294,000
BDX
Becton, Dickinson and
3.1056 of 5 stars
$234.48
+0.7%
$271.89
+16.0%
-10.2%$66.57B$18.87B44.2477,000
This page (NASDAQ:ISRG) was last updated on 3/22/2023 by MarketBeat.com Staff